Shuttle Pharmaceuticals Holdings (SHPH) Interest Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $300000.0 for Q1 2026.

• On a quarterly basis, Interest Expenses rose 50.0% year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $600000.0, a 21.02% decrease from a year earlier, with the FY2025 full-year figure at $7.8 million, up 54.01% from the prior year.
• Interest Expenses rose to $300000.0 in Q1 2026 per SHPH's latest filing, from $100000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $623465.0 in Q3 2023 and bottomed at -$1.9 million in Q4 2023.
• The 5-year median for Interest Expenses is $200000.0 (2024), against an average of $116675.9.
• Biggest YoY gain for Interest Expenses was 3640.72% in 2023; the steepest drop was 10009.44% in 2023.
• Year by year, Interest Expenses stood at $19631.0 in 2022, then plunged by 10009.44% to -$1.9 million in 2023, then surged by 96.35% to -$70990.0 in 2024, then soared by 240.86% to $100000.0 in 2025, then soared by 200.0% to $300000.0 in 2026.
• Per Business Quant, the three latest SHPH Interest Expenses figures stand at $300000.0 (Q1 2026), $100000.0 (Q3 2025), and $312998.0 (Q2 2025).